.png){kind=icon}
返回
Chronic Constipation
.png){kind=icon}
OA
AI
DOI：10.1016/j.mayocp.2019.01.031.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Constipation is a common symptom that may be primary (idiopathic or functional) or associated with a number of disorders or medications. Although most constipation is self-managed by patients, 22% seek health care, mostly to primary care physicians (>50%) and gastroenterologists (14%), resulting in large expenditures for diagnostic testing and treatments. There is strong evidence that stimulant and osmotic laxatives, intestinal secretagogues, and peripherally restricted m-opiate antagonists are effective and safe; the lattermost drugs are a major advance for managing opioid-induced constipation. Constipation that is refractory to available laxatives should be evaluated for defecatory disorders and slow-transit constipation using studies of anorectal function and colonic transit. Defecatory disorders are often responsive to biofeedback therapies, whereas slow-transit constipation may require surgical intervention in selected patients. Both efficacy and cost should guide the choice of treatment for functional constipation and opiate-induced constipation. Currently, no studies have compared inexpensive laxatives with newer drugs that work by other mechanisms. (C) 2019 Mayo Foundation for Medical Education and Research.
Keyword:
IRRITABLE-BOWEL-SYNDROME
CHRONIC IDIOPATHIC CONSTIPATION
RESOLUTION ANORECTAL MANOMETRY
SLOW-TRANSIT CONSTIPATION
PLACEBO-CONTROLLED TRIAL
OPIOID-INDUCED CONSTIPATION
DIGITAL RECTAL EXAMINATION
3350 PLUS ELECTROLYTES
DIRECT MEDICAL COSTS
LONG-TERM EFFICACY
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.7
论文数:
1.0W
被引数:
2.0W
机构
引用论文
.png){kind=icon}
Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation
OAAI
OAAI分享收藏分享收藏The incidence rate and characteristics of clinically diagnosed defecatory disorders in the communityOAAI
OAAI分享收藏
查看更多内容